Aldeyra Therapeutics (ALDX) Reports Q1 Loss of $0.37/Share

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.37), versus ($0.51) reported last year.

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
• Lululemon (LULU) PT Lowered to $115 at Freedom Broker